Indication
Bladder Transitional Cell Carcinoma
2 clinical trials
2 products
2 drugs
Product
VLS-1488Clinical trial
A Phase I/II Study of VLS-1488 (an Oral KIF18A Inhibitor) in Subjects With Advanced CancerStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Phase Ib/II Trial of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial CancerStatus: Completed, Estimated PCD: 2016-04-11
Drug
CisplatinDrug
GemcitabineProduct
ALT-801